A B S T R AC T
Background. Desmopressin (dDAVP) induces a decrease in immunolabelling of aquaporin (AQP) 4 protein in the terminal inner medulla (IM) of the Brattleboro (BB) rat kidney. It is disputed, however, whether the decreased labelling reflects real down-regulation of protein abundance, or whether it is a result of epitope shielding in the AQP4 protein, preventing binding of the antibody as previously suggested. Furthermore, it is unknown if vasopressin regulates AQP4 in the connecting tubule (CNT) and in the cortical collecting duct (CCD). Using BB rats, we aimed to determine (i) whether the dDAVPinduced decrease in AQP4 labelling in the terminal IM reflects down-regulation in protein abundance and (ii) whether dDAVP increases the AQP4 protein abundance in the CNT and the CCD. Methods. BB rats received dDAVP or saline (control) via osmotic minipumps pumps for 6 days. Results. Immunolight microscopy revealed strong AQP4 labelling in the initial inner medullary collecting duct (IMCD 1 ), weak labelling in the middle IMCD (IMCD 2 ) and weak/absent labelling in the terminal IMCD (IMCD 3 ) after 6 days of dDAVP administration. AQP3 labelling was similar to that of AQP4. Two-hour administration with dDAVP ( previously described BB rats) did not change the labelling pattern of AQP4, suggesting that potential acute phosphorylation did not induce epitope shielding, thereby preventing the binding of the antibody. Conclusions. In BB rats, long-term administration with dDAVP (i) increased the AQP4 protein abundance in the IMCD 1 and decreased the abundance in the IMCD 2 and the IMCD 3 , and (ii) increased the AQP4 protein abundance in the CNT and the CCD.
I N T RO D U C T I O N
Aquaporin (AQP) 4 is implicated in a number of pathological conditions such as brain oedema [1] and adriamycin-induced nephrotic syndrome [2] . It is a member of the AQP water channel family, which is pivotal for the maintenance of body water homeostasis by facilitating osmotic water transport across cell membranes (reviewed in [3, 4] ). In the kidney, the final water reabsorption takes place in connecting tubule (CNT) cells, collecting duct (CD) principal cells and inner medullary CD (IMCD) cells [5, 6] through AQP2, 3 and 4 (reviewed in [3, 4] ). AQP2 is found in the CNT and along the entire length of the CD in which it is localized mainly to the apical plasma membrane [7] . Basolateral expression is, however, found in the CNT and the inner medulla (IM) [8] . AQP3 is expressed in the basolateral plasma membrane of the CNT and the CD [9] [10] [11] . AQP4 is predominantly expressed in the IMCD and decreases gradually in abundance towards the cortex [12] . Subcellularly, AQP4 is exclusively localized to the basolateral plasma membrane [12] .
Body water homeostasis is regulated by the peptide hormone, arginine vasopressin (AVP). AVP is synthesized in the supraoptic and paraventricular nuclei of hypothalamus and is released in response to increased plasma osmolality or reduction in effective circulating blood volume (reviewed in [13] ). In the kidney, AVP binds to the AVP-V 2 -receptor (AVP-V 2 R) in the basolateral plasma membrane, leading to increased water permeability and urinary concentrating capacity (reviewed in [4] ). The AQP2 protein is regulated both by changes in trafficking (short-term regulation [7] ) and in abundance (long-term regulation [7, 14] ). In contrast, there is no evidence of short-term regulation of AQP3 [15] , whereas 2 days of dehydration [10] or 5 days of administration with the AVP-V 2 R specific agonist, desmopressin (dDAVP) [14] , increases the AQP3 protein abundance in AVP-deficient Brattleboro (BB) rats (central diabetes insipidus animal model).
Conflicting results exist regarding a potential regulatory role of AVP on renal AQP4. At the mRNA level, MurilloCarretero et al. [16] showed in Wistar rats that 2.5 days of water loading decreased the cortical and medullary AQP4 mRNA abundance, whereas 2.5 days of water deprivation increased the cortical AQP4 mRNA abundance. At the protein level, Terris et al. [14] found no change in renal AQP4 protein abundance after 5 days of dDAVP administration in BB rats. Using the same animal model, however, Van Hoek et al. [17] recently demonstrated increased AQP4 protein abundance in the kidney medulla after 8 days of dDAVP administration. Furthermore, they found differential immunolabelling intensity of AQP4 within the IM, possibly related to dDAVP-induced epitope shielding of the AQP4 C-terminus [17] . It is, moreover, unknown whether AVP regulates AQP4 in the CNT and in the cortical collecting duct (CCD).
We aimed to determine (i) whether the dDAVP-induced decrease in AQP4 labelling in the terminal IM reflects downregulation in protein abundance and (ii) whether dDAVP increases the AQP4 protein abundance in the CNT and the CCD. The BB rats received dDAVP via osmotic minipumps for 6 days. Analyses were conducted using immunohistochemistry at the light and electron microscopic level.
M AT E R I A L S A N D M E T H O D S
Experimental animals and protocols Adult male BB rats were obtained from Harlan Laboratories (IN). Experiments were performed in metabolic cages in which the BB rats had free access to water and rat chow for the duration of the study. Using osmotic minipumps (Alzet model 2001, Alza Corporation, Palo Alto, CA) implanted subcutaneously, BB rats were subjected to either saline administration [control; mean ± SEM, body weight (BW): 228 ± 5 g, n = 6] or dDAVP (Sigma-Aldrich, St. Louis, MO) administration (BW: 223 ± 5 g, n = 6) at a constant rate of 250 ng day -1 for 6 days (the BW was measured on Day 6). During the study, the urine output was recorded and urine samples were collected for measuring urine osmolality (U osm ). On Day 6, kidney tissue was collected for immunolight microscopy as described below. Moreover, tissue was used from our previously described BB rats [8] that had been administered with saline or dDAVP for 6 days [saline (n = 5), dDAVP (n = 6); used for immunoelectron microscopic examination in the present study] or for 2 h [saline (n = 6); dDAVP (n = 6); used for immunolight microscopic examination in the present study]. Experimental protocols applied were in agreement with the licence issued by the Danish Ministry of Justice for the use of research animals.
Immunolight microscopy Fixation. The left kidney was retrograde perfusion fixed via the abdominal aorta with 3% paraformaldehyde in 100 mM sodium cacodylate ( pH 7.4) followed by post-fixation for 1 h.
O R I G I N A L A R T I C L E
d D A V P i n d u c e s r e g u l a t i o n o f A Q P 4 i n r e n a l I M a n d c o r t e x Tissue blocks from whole kidneys were dehydrated in ethanol (2 h in 70, 96 and 99%, respectively), incubated in xylene overnight, and embedded in paraffin.
Preparation of tissue. Paraffin sections (2 µm) were cut using a Leica RM 2126 microtome (Leica, Wetzlar, Germany) and dried overnight at 37°C. The sections were dewaxed and rehydrated, after which endogenous peroxidase was blocked by 0.5% H 2 O 2 in methanol for 10 min at room temperature. To reveal antigens, sections were put in 1 mM Tris solution ( pH 9.0) supplemented with 0.5 mM EGTA and microwaveheated for 10 min. Non-specific binding of immunoglobulin G (IgG) was prevented by incubating the sections in 50 mM NH 4 Cl [dissolved in 10 mM PBS (7 mM Na 2 HPO 4 , 3 mM NaH 2 PO 4 , 150 mM NaCl, pH 7.4)] for 30 min followed by blocking in 10 mM PBS supplemented with 1% BSA, 0.05% saponin and 0.2% gelatine. Sections were incubated overnight at 4°C with the following affinity-purified polyclonal primary rabbit antibodies (raised to the C-terminal): AQP4 (Alomone, Jerusalem, Israel; dilution: 6 days dDAVP 1:2500, 2 h dDAVP 1:1200), AQP3 RA 1591 (dilution: 1:100) [18, 19] , AQP2 H7661 (dilution: 1:3000) [20] and AQP1 2353 (dilution: 1:100) [21] . A preabsorption control was performed to test the AQP4 antibody specificity (dilution: antibody 1:800, peptide 1:266). The primary antibody was diluted in 10 mM PBS supplemented with 0.1% BSA and 0.3% Triton X-100. Subsequently, the sections were rinsed with 10 mM PBS supplemented with 0.1% BSA, 0.05% saponin and 0.2% gelatine for 3 × 10 min and incubated with horseradish peroxidase-conjugated goat anti-rabbit IgG secondary antibody (Dako P448, Dako, Glostrup, Denmark; dilution: 1:200) diluted in PBS supplemented with 0.1% BSA and 0.3% Triton X-100 for 1 h at room temperature followed by incubation with diaminobenzidine. Microscopic examination was carried out using a Leica DMRE light microscope equipped with a digital camera (Leica).
Immunoelectron microscopy Ultrathin cryosections (80 nm) of the proximal part of the IM were cut on an ultra-cryomicrotome (Reichert Ultracut S, Leica, Wetzlar, Germany) and preincubated in 10 mM PBS with 0.1% skimmed milk powder and 50 mM glycine. The sections were incubated overnight at 4°C with primary AQP4 rabbit antibody (Alomone, Jerusalem, Israel, dilution: 1:6000) diluted in 10 mM PBS containing 0.1% skimmed milk powder. The primary antibody was visualized by incubation for 1 h at room temperature with secondary goat anti-rabbit IgG conjugated to 10 nm colloidal gold particles (GAR.EM10, Bio-Cell Research Laboratories, Cardiff, UK; dilution: 1:50) diluted in PBS with 0.1% skimmed milk powder and 0.06% polyethyleneglycol. Electron micrographs were taken on a Morgagni 268D FEI electron microscope (FEI, The Netherlands).
Statistical analysis
Data on urine output (confined to measurements at baseline and on Day 6) meet the statistical assumptions of normality and homoscedasticity in accordance with Sokal and Rohlf [22] and were analysed using a two-way repeatedmeasures ANOVA followed by a Holm-Sidak pair-wise multiple comparisons procedure. Analysis of U osm data was carried out using a two-sided t-test assuming unequal variance. The tests were run by SigmaStat 3.0.1a (Systat Software, San Jose, CA, USA) or SPSS 10.0.5 (SPSS Inc., Chicago, IL, USA) for Windows. All values are presented as mean ± SEM.
R E S U LT S
Urine output and urine osmolality Data on urine output showed a highly significant interaction between time and administration (P < 0.001). The urine output was clearly reduced after 6 days of dDAVP administration in BB rats (baseline: 0.85 ± 0.11 mL 24 h −1 g −1 BW, 6 days: 0.07 ± 0.01 mL 24 h −1 g −1 BW; P < 0.001), whereas there was no significant difference within the control group (baseline: 0.98 ± 0.04 mL 24 h −1 g −1 BW, 6 days: 0.97 ± 0.03 mL 24 h −1 g −1 BW, P = 0.871). The urine output in the dDAVP-administered BB rats was markedly lower after 6 days compared with the control (P < 0.001), whereas no difference was evident at the baseline (P = 0.130). Furthermore, the U osm was significantly higher in the dDAVP-administered BB rats (control: 104 ± 1 mOsm kg −1 H 2 O; dDAVP: 2097 ± 80 mOsm kg
H 2 O; P < 0.001). Collectively, there was a clear effect of the dDAVP administration.
AQP4, 3 and 2 protein localization
In the control, immunolight microscopy revealed weak labelling of AQP4 in the basolateral plasma membrane domains of CNT cells and CCD principal cells ( Figure 1A and B) , whereas more prominent cell labelling was observed in the inner stripe of the outer medullary collecting duct (ISOMCD) and in the initial, middle and the terminal IMCD (the IMCD 1 , IMCD 2 and the IMCD 3 , respectively; Figure 1C-F) . The dDAVP administration markedly increased the basolateral plasma membrane domain labelling of AQP4 in the CNT, CCD, ISOMCD and the IMCD 1 ( Figure 1G-J) , whereas the labelling was very weak/absent in the IMCD 2 and the IMCD 3 ( Figure 1K -L) compared with the control (Figure 1E-F) . Immunoelectron microscopy confirmed the dDAVP-induced increase in AQP4 abundance at the basolateral plasma membrane of the IMCD 1 principal cells (Figure 2 ). Immunolight microscopic preabsorption on sections from a control BB rat and a dDAVP-administered BB rat demonstrated no labelling when the AQP4 antibody was pre-incubated with peptide, whereas the AQP4 antibody alone clearly labelled the basolateral plasma membrane domains (Supplementary Figure S1) .
We investigated whether the dDAVP stimulation decreased the AQP3 abundance in parallel with AQP4 in the basolateral plasma membrane domains of the IMCD 2 Figure 3J ) compared with the control ( Figure 3D ) and a weaker labelling in the IMCD 2 and the IMCD 3 ( Figure 3K and L) compared with the control (Figure 3E and F). AQP3 labelling was, moreover, clearly increased by dDAVP in the CNT, CCD and the ISOMCD ( Figure 3G -I) compared with the control (Figure 3A-C) . We, furthermore, confirmed that AQP2 trafficking to the apical membrane occurred (Figure 3) , as we have previously described [8] . In the control, AQP2 was located intracellularly in the IMCD 1 , IMCD 2 and the IMCD 3 , and some cells, moreover, showed labelling in the basolateral plasma membrane domains ( Figure 3P-R) . In the CNT of the control, AQP2 labelling tended to be localized to the basolateral plasma membrane domains ( Figure 3M) , whereas in the CCD and ISOMCD, labelling was most pronounced in the apical plasma membrane domains ( Figure 3N and O) . In the dDAVP-infused BB rats, AQP2 labelling was detected in the apical plasma membrane domains in the CNT and along the entire CD ( Figure 3S-Y) , but also labelling of basolateral plasma membrane domains was found in the CNT and the CCD ( Figure 3S and T). This is in agreement with our previous data [8] .
To investigate whether the decreased labelling of AQP4 in the IMCD could occur as a result of dDAVP-induced conformational changes or epitope shielding [17, 23] , we examined kidney sections from BB rats subjected to 2 h of dDAVP administration [8] . No difference in AQP4 labelling was detected between control BB rats ( Figure 4A -C) and dDAVPinfused BB rats ( Figure 4D-F) .
We labelled for AQP1 to rule out that a potential vasoconstriction in the IM induced by long-term dDAVP administration could cause incomplete perfusion fixation and thereby decrease the general immunoreactivity of the middle and terminal part of IM. No changes in AQP1 labelling were observed between control BB rats (Supplementary Figure S2A-C) and the BB rats administered with dDAVP (Supplementary Figure S2D-F) .
D I S C U S S I O N
Immunolight microscopy revealed strong AQP4 labelling in the IMCD 1 , weak labelling in the IMCD 2 and weak/absent labelling in the IMCD 3 after 6 days of dDAVP administration. The results are in agreement with Van Hoek et al. [17] . They concluded that weak/no AQP4 labelling in the terminal IM was unexpected, because western blotting analysis of whole IM revealed no apparent difference in the total AQP4 protein abundance. The discrepancy was suggested to be related to a dDAVP-induced epitope shielding of the AQP4 C-terminus, resulting in incomplete labelling of tissue sections [17] . A potential epitope shielding could be related to conformational changes due to the phosphorylation of AQP4. In that case, a decrease in AQP4 staining after 2 h of dDAVP administration would be expected, because potential short-term regulatory mechanisms such as phosphorylation (AQP4 phosphorylation reviewed in [24] ) typically occur F I G U R E 1 : Immunolight microscopic examination of AQP4 protein abundance in the renal CNT, CCD, ISOMCD, IMCD 1 , IMCD 2 and the IMCD 3 in a tissue section from a control BB rat (A-F) and from a BB rat subjected to 6 days of dDAVP administration (G-L). In the control BB rat, weak labelling was detected in the basolateral plasma membrane domains of CNT cells and CCD principal cells (A and B, arrows), whereas more prominent basolateral labelling was detected in principal cells and IMCD cells of the ISOMCD, IMCD 1 , IMCD 2 and the IMCD 3 (C-F). In the dDAVP-infused BB rat, in contrast, strong basolateral labelling was detected in the CNT, CCD, ISOMCD and IMCD 1 (G-J), whereas basolateral labelling was very weak/absent in the IMCD 2 and the IMCD 3 (K and L). Scale bar: 10 µm.
O R I G I N A L A R T I C L E
d D A V P i n d u c e s r e g u l a t i o n o f A Q P 4 i n r e n a l I M a n d c o r t e x within 30-60 min [25, 26] . Two hours of dDAVP administration in BB rats did, however, not result in reduced labelling intensity, indicating that the potential phosphorylation of AQP4 did not reduce the binding affinity of the antibody. Alternatively, epitope shielding could occur due to a dDAVP-induced structural change in orthogonal array particles [17, 23] , which are basolateral plasma membrane structures composed of the AQP4 isoforms, M1 and M23 [17, 23, 27, 28] . In the present study, the AQP3 labelling in IM changed in parallel to that of AQP4. Although it cannot be excluded that epitope shielding of AQP3 occurred, our data favoured an overall decrease in the IMCD 2 and the IMCD 3 water permeability of the basolateral plasma membrane after longterm dDAVP administration.
AVP is known to reduce the medullary blood flow, involving the action of the receptors AVP-V 1 -R and AVP-V 2 -R [29, 30] . To rule out that a potential vasoconstriction in the IM could cause incomplete perfusion fixation of the middle and terminal part of IM and could thereby potentially account for the decreased AQP4 and AQP3 labelling, we labelled for AQP1. AQP1 is expressed in the descending thin limbs and descending vasa recta in the IM [31] and is not regulated by vasopressin [4, 14] . We found no changes in AQP1 abundance between the control and the dDAVP-administered BB rats, indicating that the general immunoreactivity of the tissue was not changed after the dDAVP administration.
We are the first to demonstrate increased AQP4 protein abundance in the CNT and CCD after long-term dDAVP administration. Using western blotting, Terris et al. [14] found no change in renal AQP4 abundance in response to 5 days of dDAVP administration in BB rats. In contrast, Van Hoek et al. [17] showed that, in BB rats, 8 days of dDAVP administration up-regulated the abundance of AQP4 in the outer medulla (OM), which is consistent with our data. They did not, however, describe regulation in the cortex. Terris et al. [14] found a statistically significant increase in AQP3 abundance in the IM and the OM compared with the control, while there was a tendency to an up-regulation in the cortex. We showed that long-term dDAVP administration increased the abundance of AQP3 in the CNT, CCD, ISOMCD and the IMCD 1 compared with the control and decreased the abundance in the IMCD 2 and the IMCD 3 . Thus, our results provide novel insight into renal the regulation of both AQP4 and AQP3 protein abundance.
Chou et al. [32] demonstrated that in AQP4 knock-out mice, isolated IMCD 1 tubules showed markedly decreased transepithelial osmotic water permeability compared with the control [32] . A similar importance of AQP4 could be found in the IMCD 2 and the IMCD 3 . Thus, the low abundance of AQP4 and AQP3 in IMCD 2 and IMCD 3 demonstrated in the present study might reflect decreased basolateral plasma membrane water permeability in these tubule segments after long-term dDAVP administration. Micropuncture experiments in BB rats subjected to acute dDAVP administration showed that the fraction of water reabsorbed in the terminal part of IM (corresponds likely to IMCD 3 ) is lower during antidiuresis (AVP administration) than during diuresis [33] . The lower water reabsorption might be connected to a reduction in the osmotic gradient [33] . It could be speculated that long-term dDAVP administration to BB rats limited the relative amount of fluid that reached the IMCD 2 and the IMCD 3 due to a more abundant reabsorption upstream. This could reduce the requirement of water reabsorption across the IMCD 2 and the IMCD 3 , leading to reduced AQP4 abundance in the IMCD 2 and the IMCD 3 . The hypothesis is in agreement with Chou et al. [32] who found no concentration defect in AQP4 knock-out mice examined during antidiuretic conditions.
Morphologically, IMCD cells (exclusively found in the IMCD 2 and the IMCD 3 ) differ from principal cells in the IMCD 1 and the IMCD 2 . IMCD cells are taller, have fewer basal infoldings and have a lighter staining cytoplasm compared with principal cells [5, 6] . Moreover, IMCD cells do not contain a cilium on the luminal surface. The fact that IMCD cells are morphologically different from principal F I G U R E 2 : Immunoelectron microscopic examination of AQP4 protein abundance in renal IMCD 1 principal cells in a tissue section from a control BB rat (A) and from a BB rat subjected to 6 days of dDAVP administration (B). In the dDAVP-infused BB rat, more intense AQP4 labelling was detected at the basolateral plasma membrane (B, arrows) compared with the control (A, arrows). BM, basement membrane. Scale bar: 0.5 µm.
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F I G U R E 3 :
Immunolight microscopic examination of AQP3 (A-L) and AQP2 (M-Y) protein abundance in the renal CNT, CCD, ISOMCD, IMCD 1 , IMCD 2 and the IMCD 3 in tissue sections from a control BB rat and a BB rat subjected to 6 days of dDAVP administration. In the control BB rat, AQP3 labelling was detected in the basolateral plasma membrane domains in the CNT, CCD, ISOMCD, IMCD 1 , IMCD 2 and the IMCD 3 (A-F). In the dDAVP-infused BB rat, prominent AQP3 labelling was detected in the basolateral plasma membrane domain of the CNT, CCD, ISOMCD and the IMCD 1 (G-J), whereas labelling of the IMCD 2 (labelling predominantly lateral) and the IMCD 3 was weak/absent (K and L). AQP2 labelling in the control BB rat tended to be localized to the basolateral plasma membrane domains of the CNT (M, arrows). In the CCD and ISOMCD, labelling was most pronounced in the apical plasma membrane domains (N and O, arrows). In the IMCD 1 , IMCD 2 and the IMCD 3 , labelling was intracellular, and some cells, moreover, showed labelling in the basolateral plasma membrane domains as well (P-R, arrows). In the dDAVP-infused BB rat, both labelling of basolateral and apical plasma membrane domains was found in the CNT and the CCD (S and T). In the ISOMCD, IMCD 1 , IMCD 2 and the IMCD 3 , labelling was mainly detected in the apical cell membrane domains (U-Y). Scale bar: 10 µm.
O R I G I N A L A R T I C L E
d D A V P i n d u c e s r e g u l a t i o n o f A Q P 4 i n r e n a l I M a n d c o r t e x cells could indicate that the regulation of gene expression is different in the IMCD 2 and IMCD 3 compared with the IMCD 1 . This could be correlated with the different regulation of AQP4 and AQP3 along the IMCD. Furthermore, tissue-specific factors might contribute to the different abundance ratios of the AQP4 isoforms, M1 and M23, in different tissues [34] . A transcriptional regulator of AQP4, miR-130a, is expressed in the brain [35] , but whether a similar renal transcription factor of AQP4 is affected by dDAVP is unknown. Furthermore, long-term dDAVP administration induces renal medullary hypoxia, which upregulates hypoxia-inducible genes [36] , but it is unknown how hypoxia affects the AQP4 abundance. Collectively, further studies are needed to elucidate the mechanistic basis underlying the dDAVP-induced down-regulation of AQP4 in the IMCD 2 and IMCD 3 .
In conclusion, we showed that long-term administration with dDAVP in BB rats (i) increased the AQP4 protein abundance in the IMCD 1 and decreased the abundance in the IMCD 2 and the IMCD 3 , and (ii) increased the AQP4 protein abundance in the CNT and the CCD. The conclusion manifests that AQP4 is regulated by long-term dDAVP administration.
S U P P L E M E N TA RY D ATA
Supplementary data are available online at http://ndt.oxfordjournals.org.
